February Newsletter:Interview with Dr. Simon Pedder,
acting CEO of Cellectar Biosciences Inc.
This month, we speak with Dr. Simon Pedder, acting CEO of Cellectar Biosciences Inc. (OTCQX: CLRB). The company, which joined OTCQX in February 2012, recently underwent a strategic realignment that included organizational changes and a corporate name change. Dr. Pedder talks with us about the company’s growth strategy going forward.
OTC Market Tiers - Helping Investors Navigate the OTC Market
The Best Marketplace with
- OTCM's February Newsletter
- OTCM ADR Index Rose 5.3% in Fourth Quarter, 18.7% for Full Year 2013 – Press Release
- Tick pilot for illiquid stocks gains momentum – The Trade News
- OTC Markets Group Provides Real-Time Level 1 and Level 2 Data to REDI Global Technologies LLC – Press Release
- Banks Hunt for Liquidity To Boost Stock Prices, M&A– American Banker
- FINRA Warns Investors About The Potential for Stock Scams Associated with Marijuana-Related Stocks
- See where you can access Market Data
OTC MARKETS NEWS & UPDATES